Manulife (Manufacturers Life Insurance)’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $734K | Buy |
212,126
+6,547
| +3% | +$22.7K | ﹤0.01% | 1966 |
|
|
2025
Q1 | $539K | Sell |
205,579
-13,293
| -6% | -$34.8K | ﹤0.01% | 2108 |
|
|
2024
Q4 | $902K | Buy |
218,872
+3,325
| +2% | +$13.7K | ﹤0.01% | 1955 |
|
|
2024
Q3 | $1.53M | Sell |
215,547
-41
| -0% | -$290 | ﹤0.01% | 1693 |
|
|
2024
Q2 | $1.41M | Sell |
215,588
-19,598
| -8% | -$128K | ﹤0.01% | 1660 |
|
|
2024
Q1 | $1.95M | Sell |
235,186
-3,870
| -2% | -$32.1K | ﹤0.01% | 1525 |
|
|
2023
Q4 | $2.63M | Sell |
239,056
-1,040
| -0.4% | -$11.5K | ﹤0.01% | 1384 |
|
|
2023
Q3 | $2.02M | Buy |
240,096
+34,535
| +17% | +$290K | ﹤0.01% | 1433 |
|
|
2023
Q2 | $2.58M | Buy |
205,561
+37,406
| +22% | +$470K | ﹤0.01% | 1331 |
|
|
2023
Q1 | $2.77M | Buy |
168,155
+61,822
| +58% | +$1.02M | ﹤0.01% | 1302 |
|
|
2022
Q4 | $1.58M | Buy |
106,333
+3,188
| +3% | +$47.3K | ﹤0.01% | 1451 |
|
|
2022
Q3 | $2.36M | Buy |
103,145
+6,977
| +7% | +$160K | ﹤0.01% | 1342 |
|
|
2022
Q2 | $1.61M | Buy |
96,168
+7,606
| +9% | +$128K | ﹤0.01% | 1474 |
|
|
2022
Q1 | $2.69M | Buy |
88,562
+53,376
| +152% | +$1.62M | ﹤0.01% | 1431 |
|
|
2021
Q4 | $1.1K | Buy |
35,186
+3,992
| +13% | +$124 | ﹤0.01% | 1770 |
|
|
2021
Q3 | $984K | Sell |
31,194
-1,955
| -6% | -$61.7K | ﹤0.01% | 1854 |
|
|
2021
Q2 | $1.21M | Buy |
33,149
+7,020
| +27% | +$257K | ﹤0.01% | 1877 |
|
|
2021
Q1 | $903K | Buy |
26,129
+6,345
| +32% | +$219K | ﹤0.01% | 1952 |
|
|
2020
Q4 | $822K | Buy |
19,784
+2,187
| +12% | +$90.9K | ﹤0.01% | 1936 |
|
|
2020
Q3 | $749K | Buy |
+17,597
| New | +$749K | ﹤0.01% | 1794 |
|